ANIX

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

ANIX Stock Price: Over 15% Increase Pre-Market Explanation

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

Anixa's Stock Craters As FDA Slaps Clinical Hold On CAR-T Program

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy